chitosan has been researched along with Peripheral Arterial Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, YH; Hsiao, CY; Tsai, KL; Wang, CY | 1 |
| Albrecht-Schgoer, K; Barthelmes, J; Bernkop-Schnürch, A; Dünnhaupt, S; Gutmann, C; Kirchmair, R; Lener, D; Nardin, I; Schgoer, W; Theurl, M | 1 |
2 other study(ies) available for chitosan and Peripheral Arterial Disease
| Article | Year |
|---|---|
Injectable thermosensitive chitosan-based hydrogel containing ferulic acid for treating peripheral arterial disease.
Topics: Animals; Apoptosis; Chitosan; Coumaric Acids; Gene Expression Regulation; Hindlimb; Human Umbilical Vein Endothelial Cells; Humans; Hydrogels; Injections; Mice, Inbred C57BL; MicroRNAs; Mitochondria; Peripheral Arterial Disease; Reactive Oxygen Species; Temperature | 2020 |
Nanoparticular delivery system for a secretoneurin derivative induces angiogenesis in a hind limb ischemia model.
Topics: Angiogenesis Inducing Agents; Animals; Apoptosis; Cell Proliferation; Chitosan; Chromatography, High Pressure Liquid; Drug Delivery Systems; Endothelium, Vascular; Hindlimb; Human Umbilical Vein Endothelial Cells; Humans; Ischemia; Mice; Muscle, Skeletal; Nanoparticles; Neovascularization, Physiologic; Neuropeptides; Particle Size; Peripheral Arterial Disease; Secretogranin II | 2017 |